Are circulating monocytes as microglia orthologues appropriate biomarker targets for neuronal diseases?

Central Nervous System Agents in Medicinal Chemistry

Volumn 9, Issue 4, 2009, Pages 307-330

  Schmitz, Gerd ^a   Leuthäuser Jaschinski, Kerstin ^a   Orsó, Evelyn ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Alzheimer's disease; Macrophage; Microglia; Monocyte; Neurodegeneration; Neuroinflammation

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BLOOD; DEMENTIA; GENE MAPPING; HIV ASSOCIATED DEMENTIA; HUMAN; INFLAMMATION; MACROPHAGE; MICROGLIA; MONITORING; MONOCYTE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROLOGIC DISEASE; NIEMANN PICK DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROGNOSIS; REVIEW;

EID: 70449717860     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152409789630424     Document Type: Review

References (268)

1. Vaughan, D.W.; Peters, A. Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J. Neurocytol., 1974, 3(4), 405-429.
2. Chan, W.Y.; Kohsaka, S.; Rezaie, P. The origin and cell lineage of microglia: new concepts. Brain Res. Rev., 2007, 53(2), 344-354. (Pubitemid 46177241)
3. Djukic, M.; Mildner, A.; Schmidt, H.; Czesnik, D.; Bruck, W.; Priller, J.; Nau, R.; Prinz, M. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain, 2006, 129(Pt 9), 2394-2403.
4. Flugel, A.; Bradl, M.; Kreutzberg, G.W.; Graeber, M.B. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J. Neurosci. Res., 2001, 66(1), 74-82.
5. Ladeby, R.; Wirenfeldt, M.; Garcia-Ovejero, D.; Fenger, C.; ssing-Olesen, L.; Dalmau, I.; Finsen, B. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev., 2005, 48(2), 196-206.
6. Lawson, L.J.; Perry, V.H.; Gordon, S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience, 1992, 48(2), 405-415.
7. Guerreiro, R.J.; Santana, I.; Bras, J.M.; Santiago, B.; Paiva, A.; Oliveira, C. Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener. Dis., 2007, 4(6), 406-412. (Pubitemid 47557281)
8. Sala, G.; Galimberti, G.; Canevari, C.; Raggi, M.E.; Isella, V.; Facheris, M.; Appollonio, I.; Ferrarese, C. Peripheral cytokine re lease in Alzheimer patients: correlation with disease severity. Neurobiol. Aging, 2003, 24(7), 909-914. (Pubitemid 36962975)
9. Gordon, S.; Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol., 2005, 5(12), 953-964.
10. Schmitz, G.; Grandl, M. Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation. Antioxid. Redox. Signal., 2007, 9(9), 1499-1518. (Pubitemid 47255028)
11. Fogg, D.K.; Sibon, C.; Miled, C.; Jung, S.; Aucouturier, P.; Littman, D.R.; Cumano, A.; Geissmann, F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science, 2006, 311(5757), 83-87. (Pubitemid 43063063)
12. Whitelaw, D.M. Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet., 1972, 5(4), 311-317.
13. Rothe, G.; Herr, A.S.; Stohr, J.; Abletshauser, C.; Weidinger, G.; Schmitz, G. A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis, 1999, 144(1), 251-261. (Pubitemid 29259986)
14. Schmitz, G.; Orso, E.; Rothe, G.; Klucken, J. Scavenging, signalling and adhesion coupling in macrophages: implications for atherogenesis. Curr. Opin. Lipidol., 1997, 8(5), 287-300.
15. Stohr, J.; Schindler, G.; Rothe, G.; Schmitz, G. Enhanced upregulation of the Fc gamma receptor IIIa(CD16a) during in vitro differentiation of ApoE4/4 monocytes. Arterioscler. Thromb. Vasc. Biol., 1998, 18(9), 1424-1432. (Pubitemid 28421880)
16. Weber, C.; Belge, K.U.; von Hundelshausen, P.; Draude, G.; Steppich, B.; Mack, M.; Frankenberger, M.; Weber, K.S.; Ziegler-Heitbrock, H.W. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol., 2000, 67(5), 699-704.
17. Lutter, D.; Ugocsai, P.; Grandl, M.; Orso, E.; Theis, F.; Lang, E.W.; Schmitz, G. Analyzing M-CSF dependent monocyte/macrophage differentiation: expression modes and metamodes derived from an independent component analysis. BMC Bioinformatics, 2008, 9,100.
18. Delamarre, L.; Pack, M.; Chang, H.; Mellman, I.; Trombetta, E.S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science, 2005, 307(5715), 1630-1634.
19. Savill, J.; Dransfield, I.; Gregory, C.; Haslett, C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol., 2002, 2(12), 965-975. (Pubitemid 37323217)
20. Gordon, S. Macrophage heterogeneity and tissue lipids. J. Clin. Invest., 2007, 117(1), 89-93. (Pubitemid 46048455)
21. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol., 2004, 25(12), 677-686. (Pubitemid 39457982)
22. Maxfield, F.R.; Tabas, I. Role of cholesterol and lipid organization in disease. Nature, 2005, 438(7068), 612-621. (Pubitemid 41740565)
23. Schmitz, G.; Grandl, M. Lipid homeostasis in macrophages - Implications for atherosclerosis. Rev. Physiol. Biochem. Pharmacol., 2008, 160, 93-125.
24. Lawson, L.J.; Perry, V.H.; Dri, P.; Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience, 1990, 39(1), 151-170.
25. Graeber, M.B.; Streit, W.J. Perivascular microglia defined. Trends Neurosci., 1990, 13(9), 366-.
26. Hanisch, U.K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10(11), 1387-1394.
27. Davalos, D.; Grutzendler, J.; Yang, G.; Kim, J.V.; Zuo, Y.; Jung, S.; Littman, D.R.; Dustin, M.L.; Gan, W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci., 2005, 8(6), 752-758.
28. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308(5726), 1314-1318. (Pubitemid 40746128)
29. Kim, S.U.; de Vellis, J. Microglia in health and disease. J. Neurosci. Res., 2005, 81(3), 302-313.
30. Streit, W.J.; Walter, S.A.; Pennell, N.A. Reactive microgliosis. Prog. Neurobiol., 1999, 57(6), 563-581.
31. Cho, B.P.; Song, D.Y.; Sugama, S.; Shin, D.H.; Shimizu, Y.; Kim, S.S.; Kim, Y.S.; Joh, T.H. Pathological dynamics of activated microglia following medial forebrain bundle transection. Glia, 2006, 53(1), 92-102.
32. Oehmichen, W.; Gencic, M. Experimental studies on kinetics and functions of monuclear phagozytes of the central nervous system. Acta Neuropathol. Suppl., 1975, Suppl 6: 285-290
33. Rock, R.B.; Gekker, G.; Hu, S.; Sheng, W.S.; Cheeran, M.; Lokensgard, J.R.; Peterson, P.K. Role of microglia in central nervous system infections. Clin. Microbiol. Rev., 2004, 17(4), 942-964.
34. Flaris, N.A.; Densmore, T.L.; Molleston, M.C.; Hickey, W.F. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia, 1993, 7(1), 34-40.
35. Banati, R.B.; Gehrmann, J.; Schubert, P.; Kreutzberg, G.W. Cytotoxicity of microglia. Glia, 1993, 7(1), 111-118.
36. Gehrmann, J.; Matsumoto, Y.; Kreutzberg, G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev., 1995, 20(3), 269-287.
37. Gordon, S. The macrophage. Bioessays, 1995, 17(11), 977-986.
38. Simard, A.R.; Soulet, D.; Gowing, G.; Julien, J.P.; Rivest, S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron, 2006, 49(4), 489-502. (Pubitemid 43221886)
39. Wilkinson, B.; Koenigsknecht-Talboo, J.; Grommes, C.; Lee, C.Y.; Landreth, G. Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J. Biol. Chem., 2006, 281(30), 20842-20850. (Pubitemid 44115425)
40. Liao, H.; Bu, W.Y.; Wang, T.H.; Ahmed, S.; Xiao, Z.C. Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function. J. Biol. Chem., 2005, 280(9), 8316-8323.
41. Morgan, S.C.; Taylor, D.L.; Pocock, J.M. Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J. Neurochem., 2004, 90(1), 89-101.
42. Muller, F.J.; Snyder, E.Y.; Loring, J.F. Gene therapy: can neural stem cells deliver? Nat. Rev. Neurosci., 2006, 7(1), 75-84.
43. Marin-Teva, J.L.; Dusart, I.; Colin, C.; Gervais, A.; van Rooijen, N.; Mallat, M. Microglia promote the death of developing Purkinje cells. Neuron, 2004, 41(4), 535-547. (Pubitemid 38253066)
44. Upender, M.B.; Naegele, J.R. Activation of microglia during developmentally regulated cell death in the cerebral cortex. Dev. Neurosci., 1999, 21(6), 491-505.
45. Aarum, J.; Sandberg, K.; Haeberlein, S.L.; Persson, M.A. Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl. Acad. Sci. USA, 2003, 100(26), 15983-15988.
46. Walton, M.R.; Gibbons, H.; MacGibbon, G.A.; Sirimanne, E.; Saura, J.; Gluckman, P.D.; Dragunow, M. PU.1 expression in microglia. J. Neuroimmunol., 2000, 104(2), 109-115.
47. Ladeby, R.; Wirenfeldt, M.; Dalmau, I.; Gregersen, R.; Garcia-Ovejero, D.; Babcock, A.; Owens, T.; Finsen, B. Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia, 2005, 50(2), 121-131. (Pubitemid 40695266)
48. Kaur, C.; Hao, A.J.; Wu, C.H.; Ling, E.A. Origin of microglia. Microsc. Res. Tech., 2001, 54(1), 2-9.
49. Simard, A.R.; Rivest, S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J, 2004, 18(9), 998-1000. (Pubitemid 39561504)
50. Majumdar, A.; Cruz, D.; Asamoah, N.; Buxbaum, A.; Sohar, I.; Lobel, P.; Maxfield, F.R. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell, 2007, 18(4), 1490-1496.
51. Hickey, W.F.; Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science, 1988, 239(4837), 290-292 (Pubitemid 18061496)
52. Hickey, W.F.; Vass, K.; Lassmann, H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol., 1992, 51(3), 246-256.
53. Stoll, G.; Jander, S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol., 1999, 58(3), 233-247. (Pubitemid 29193056)
54. Davoust, N.; Vuaillat, C.; Androdias, G.; Nataf, S. From bone marrow to microglia: barriers and avenues. Trends Immunol., 2008, 29(5), 227-234.
55. Ulevitch, R.J.; Tobias, P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol., 1995, 13, 437-457.
56. De Simone R.; Giampaolo, A.; Giometto, B.; Gallo, P.; Levi, G.; Peschle, C.; Aloisi, F. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol., 1995, 54(2), 175-187.
57. Frei, K.; Siepl, C.; Groscurth, P.; Bodmer, S.; Schwerdel, C.; Fontana, A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol., 1987, 17(9), 1271-1278. (Pubitemid 17148166)
58. Panek, R.B.; Benveniste, E.N. Class II MHC gene expression in microglia: Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta. J. Immunol., 1995, 154(6), 2846-2854.
59. Shrikant, P.; Weber, E.; Jilling, T.; Benveniste, E.N. Intercellular adhesion molecule-1 gene expression by glial cells: differential mechanisms of inhibition by IL-10 and IL-6. J. Immunol., 1995, 155(3), 1489-1501.
60. Suzumura, A.; Mezitis, S.G.; Gonatas, N.K.; Silberberg, D.H. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J. Neuroimmunol., 1987, 15(3), 263-278.
61. Walker, D.G.; Kim, S.U.; McGeer, P.L. Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J. Neurosci. Res., 1995, 40(4), 478-493.
62. Williams, K.; Bar-Or, A.; Ulvestad, E.; Olivier, A.; Antel, J.P.; Yong, V.W. Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J. Neuropathol. Exp. Neurol., 1992, 51(5), 538-549.
63. Williams, K.; Ulvestad, E.; Antel, J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol., 1994, 24(12), 3031-3037.
64. Guillemin, G.J.; Brew, B.J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol., 2004, 75(3), 388-397.
65. Block, M.L.; Zecca, L.; Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 2007, 8(1), 57-69.
66. Colton, C.A.; Gilbert, D.L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett., 1987, 223(2), 284-288.
67. Lee, S.C.; Liu, W.; Dickson, D.W.; Brosnan, C.F.; Berman, J.W. Cytokine production by human fetal microglia and astrocytes: differential induction by lipopolysaccharide and IL-1 beta. J. Immunol., 1993, 150(7), 2659-2667.
68. Liu, B.; Gao, H.M.; Wang, J.Y.; Jeohn, G.H.; Cooper, C.L.; Hong, J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. NY Acad. Sci., 2002, 962, 318-331.
69. Moss, D.W.; Bates, T.E. Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur. J. Neurosci., 2001, 13(3), 529-538.
70. Sawada, M.; Kondo, N.; Suzumura, A.; Marunouchi, T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res., 1989, 491(2), 394-397. (Pubitemid 19163393)
71. Gao, H.M.; Hong, J.S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol., 2008, 29(8), 357-365.
72. Takeuchi, H.; Jin, S.; Wang, J.; Zhang, G.; Kawanokuchi, J.; Kuno, R.; Sonobe, Y.; Mizuno, T.; Suzumura, A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem., 2006, 281(30), 21362-21368.
73. Colton, C.A.; Mott, R.T.; Sharpe, H.; Xu, Q.; Van Nostrand, W.E.; Vitek, M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation., 2006, 3, 27.
74. Mrak, R.E.; Griffin, W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging, 2005, 26(3), 349-354.
75. Klegeris, A.; McGeer, E.G.; McGeer, P.L. Therapeutic approaches to inflammation in neurodegenerative disease. Curr. Opin. Neurol., 2007, 20(3), 351-357.
76. Dodel, R.C.; Hampel, H.; Du, Y. Immunotherapy for Alzheimer's disease. Lancet Neurol., 2003, 2(4), 215-220.
77. von Rotz, R.C.; Kohli, B.M.; Bosset, J.; Meier, M.; Suzuki, T.; Nitsch, R.M.; Konietzko, U. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci., 2004, 117(Pt 19), 4435-4448.
78. Allinson, T.M.; Parkin, E.T.; Turner, A.J.; Hooper, N.M. ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res., 2003, 74(3), 342-352.
79. Vassar, R.; Bennett, B.D.; Babu-Khan, S.; Kahn, S.; Mendiaz, E.A.; Denis, P.; Teplow, D.B.; Ross, S.; Amarante, P.; Loeloff, R.; Luo, Y.; Fisher, S.; Fuller, J.; Edenson, S.; Lile, J.; Jarosinski, M.A.; Biere, A.L.; Curran, E.; Burgess, T.; Louis, J.C.; Collins, F.; Treanor, J.; Rogers, G.; Citron, M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 1999, 286(5440), 735-741. (Pubitemid 129515714)
80. Kaether, C.; Haass, C.; Steiner, H. Assembly, trafficking and function of gamma-secretase. Neurodegener. Dis., 2006, 3(4-5), 275-283.
81. Ehehalt, R.; Keller, P.; Haass, C.; Thiele, C.; Simons, K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol., 2003, 160(1), 113-123. (Pubitemid 36091721)
82. Vetrivel, K.S.; Cheng, H.; Lin, W.; Sakurai, T.; Li, T.; Nukina, N.; Wong, P.C.; Xu, H.; Thinakaran, G. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem., 2004, 279(43), 44945-44954.
83. Rajendran, L.; Simons, K. Lipid rafts and membrane dynamics. J. Cell Sci., 2005, 118(Pt 6), 1099-1102
84. Kalvodova, L.; Kahya, N.; Schwille, P.; Ehehalt, R.; Verkade, P.; Drechsel, D.; Simons, K. Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem., 2005, 280(44), 36815-36823.
85. Sawamura, N.; Ko, M.; Yu, W.; Zou, K.; Hanada, K.; Suzuki, T.; Gong, J.S.; Yanagisawa, K.; Michikawa, M. Modulation of amyloid precursor protein cleavage by cellular sphingolipids. J Biol. Chem., 2004, 279(12), 11984-11991. (Pubitemid 38401704)
86. Grimm, M.O.; Grimm, H.S.; Tomic, I.; Beyreuther, K.; Hartmann, T.; Bergmann, C. Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J. Biol. Chem., 2008, 283(17), 11302-11311.
87. Kivipelto, M.; Helkala, E.L.; Hanninen, T.; Laakso, M.P.; Hallikainen, M.; Alhainen, K.; Soininen, H.; Tuomilehto, J.; Nissinen, A. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology, 2001, 56(12), 1683-1689. (Pubitemid 32574567)
88. Grimm, M.O.; Grimm, H.S.; Patzold, A.J.; Zinser, E.G.; Halonen, R.; Duering, M.; Tschape, J.A.; De Strooper, B.; Muller, U.; Shen, J.; Hartmann, T. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell Biol., 2005, 7(11), 1118-1123.
89. Rajendran, L.; Honsho, M.; Zahn, T.R.; Keller, P.; Geiger, K.D.; Verkade, P.; Simons, K. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA, 2006, 103(30), 11172-11177. (Pubitemid 44156491)
90. Runz, H.; Rietdorf, J.; Tomic, I.; de Bernard, M.; Beyreuther, K.; Pepperkok, R.; Hartmann, T. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J. Neurosci., 2002, 22(5), 1679-1689.
91. Vance, J.E.; Karten, B.; Hayashi, H. Lipid dynamics in neurons. Biochem. Soc. Trans., 2006, 34(Pt 3), 399-403.
92. Davignon, J.; Bouthillier, D.; Nestruck, A.C.; Sing, C.F. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans. Am. Clin. Climatol. Assoc., 1988, 99,100-110.
93. Roses, A.D. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med., 1996, 47, 387-400. (Pubitemid 26138899)
94. Irizarry, M.C.; Deng, A.; Lleo, A.; Berezovska, O.; von Arnim, C.A.; Martin-Rehrmann, M.; Manelli, A.; LaDu, M.J.; Hyman, B.T.; Rebeck, G.W. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. J. Neurochem., 2004, 90(5), 1132-1143. (Pubitemid 39167346)
95. Cagnin, A.; Brooks, D.J.; Kennedy, A.M.; Gunn, R.N.; Myers, R.; Turkheimer, F.E.; Jones, T.; Banati, R.B. In-vivo measurement of activated microglia in dementia. Lancet, 2001, 358(9280), 461-467.
96. McGeer, P.L.; Itagaki, S.; Tago, H.; McGeer, E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett., 1987, 79(1-2), 195-200.
97. Uchihara, T.; Akiyama, H.; Kondo, H.; Ikeda, K. Activated microglial cells are colocalized with perivascular deposits of amyloidbeta protein in Alzheimer's disease brain. Stroke, 1997, 28(10), 1948-1950.
98. Griffin, W.S.; Sheng, J.G.; Royston, M.C.; Gentleman, S.M.; McKenzie, J.E.; Graham, D.I.; Roberts, G.W.; Mrak, R.E. Glialneuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol., 1998, 8(1), 65-72.
99. Xiang, Z.; Haroutunian, V.; Ho, L.; Purohit, D.; Pasinetti, G.M. Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia. Dis. Markers, 2006, 22(1-2), 95-102.
100. Liu, Y.; Walter, S.; Stagi, M.; Cherny, D.; Letiembre, M.; Schulz-Schaeffer, W.; Heine, H.; Penke, B.; Neumann, H.; Fassbender, K. LPS receptor(CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain, 2005, 128(Pt 8), 1778-1789.
101. Koenigsknecht, J.; Landreth, G. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J. Neurosci., 2004, 24(44), 9838-9846. (Pubitemid 39463564)
102. Rogers, J.; Strohmeyer, R.; Kovelowski, C.J.; Li, R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia, 2002, 40(2), 260-269.
103. Streit, W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia, 2002, 40(2), 133-139.
104. Malm, T.M.; Koistinaho, M.; Parepalo, M.; Vatanen, T.; Ooka, A.; Karlsson, S.; Koistinaho, J. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis., 2005, 18(1), 134-142.
105. Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G.M.; Cooper, N.R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B.L.; Finch, C.E.; Frautschy, S.; Griffin, W.S.; Hampel, H.; Hull, M.; Landreth, G.; Lue, L.; Mrak, R.; Mackenzie, I.R.; McGeer, P.L.; O'Banion, M.K.; Pachter, J.; Pasinetti, G.; Plata-Salaman, C.; Rogers, J.; Rydel, R.; Shen, Y.; Streit, W.; Strohmeyer, R.; Tooyoma, I.; van Muiswinkel, F.L.; Veerhuis, R.; Walker, D.; Webster, S.; Wegrzyniak, B.; Wenk, G.; Wyss-Coray, T. Inflammation and Alzheimer's disease. Neurobiol. Aging, 2000, 21(3), 383-421.
106. Streit, W.J.; Mrak, R.E.; Griffin, W.S. Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation, 2004, 1(1), 14.
107. El Khoury, J.; Toft, M.; Hickman, S.E.; Means, T.K.; Terada, K.; Geula, C.; Luster, A.D. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med., 2007, 13(4), 432-438.
108. Koenigsknecht-Talboo, J.; Landreth, G.E. Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci., 2005, 25(36), 8240-8249.
109. Fan, R.; Xu, F.; Previti, M.L.; Davis, J.; Grande, A.M.; Robinson, J.K.; Van Nostrand, W.E. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J. Neurosci., 2007, 27(12), 3057-3063.
110. Mohri, I.; Kadoyama, K.; Kanekiyo, T.; Sato, Y.; Kagitani-Shimono, K.; Saito, Y.; Suzuki, K.; Kudo, T.; Takeda, M.; Urade, Y.; Murayama, S.; Taniike, M. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol., 2007, 66(6), 469-480. (Pubitemid 46869689)
111. Weggen, S.; Rogers, M.; Eriksen, J. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol. Sci., 2007, 28(10), 536-543.
112. Lleo, A.; Greenberg, S.M.; Growdon, J.H. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med., 2006, 57, 513-533
113. Parachikova, A.; Agadjanyan, M.G.; Cribbs, D.H.; Blurton-Jones, M.; Perreau, V.; Rogers, J.; Beach, T.G.; Cotman, C.W. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging, 2007, 28(12), 1821-1833.
114. Qin, L.; Liu, Y.; Cooper, C.; Liu, B.; Wilson, B.; Hong, J.S. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem., 2002, 83(4), 973-983.
115. Klegeris, A.; Walker, D.G.; McGeer, P.L. Activation of macrophages by Alzheimer beta amyloid peptide. Biochem. Biophys. Res. Commun., 1994, 199(2), 984-991
116. Klegeris, A.; McGeer, P.L. beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res., 1997, 49(2), 229-235.
117. Dheen, S.T.; Jun, Y.; Yan, Z.; Tay, S.S.; Ling, E.A. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia, 2005, 50(1), 21-31.
118. Ii, M.; Sunamoto, M.; Ohnishi, K.; Ichimori, Y. beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res., 1996, 720(1-2), 93-100 (Pubitemid 126334265)
119. Akiyama, H.; Arai, T.; Kondo, H.; Tanno, E.; Haga, C.; Ikeda, K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord., 2000, 14(Suppl 1), S47-S53.
120. Broytman, O.; Malter, J.S. Anti-Abeta: The good, the bad, and the unforeseen. J. Neurosci. Res., 2004, 75(3), 301-306.
121. Hoozemans, J.J.; Veerhuis, R.; Rozemuller, A.J.; Eikelenboom, P. The pathological cascade of Alzheimer's disease: the role of inflammation and its therapeutic implications. Drugs Today(Barc.), 2002, 38(6), 429-443. (Pubitemid 34733622)
122. Combs, C.K.; Johnson, D.E.; Cannady, S.B.; Lehman, T.M.; Landreth, G.E. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci., 1999, 19(3), 928-939.
123. Lorton, D.; Kocsis, J.M.; King, L.; Madden, K.; Brunden, K.R. beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J. Neuroimmunol., 1996, 67(1), 21-29.
124. McDonald, D.R.; Brunden, K.R.; Landreth, G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci., 1997, 17(7), 2284-2294.
125. Yankner, B.A.; Duffy, L.K.; Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science, 1990, 250(4978), 279-282. (Pubitemid 20354234)
126. Duan, R.S.; Chen, Z.; Dou, Y.C.; Concha, Q.H.; Nennesmo, I.; Adem, A.; Winblad, B.; Zhu, J. Apolipoprotein E deficiency increased microglial activation/CCR3 expression and hippocampal damage in kainic acid exposed mice. Exp. Neurol., 2006, 202(2), 373-380. (Pubitemid 44692679)
127. Galasko, D. Cerebrospinal fluid biomarkers in Alzheimer disease: a fractional improvement? Arch. Neurol., 2003, 60(9), 1195-1196. (Pubitemid 37099622)
128. Graff-Radford, N.R.; Crook, J.E.; Lucas, J.; Boeve, B.F.; Knopman, D.S.; Ivnik, R.J.; Smith, G.E.; Younkin, L.H.; Petersen, R.C.; Younkin, S.G. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch. Neurol., 2007, 64(3), 354-362.
129. Ripova, D.; Strunecka, A. An ideal biological marker of Alzheimer's disease: dream or reality? Physiol. Res., 2001, 50(2), 119-129.
130. Turner, R.S. Biomarkers of Alzheimer's disease and mild cognitive impairment: are we there yet? Exp. Neurol., 2003, 183(1), 7-10. (Pubitemid 37075851)
131. Thomas, D.M.; Francescutti-Verbeem, D.M.; Kuhn, D.M. Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage. FASEB J, 2006, 20(3), 515-517.
132. Colton, C.A.; Needham, L.K.; Brown, C.; Cook, D.; Rasheed, K.; Burke, J.R.; Strittmatter, W.J.; Schmechel, D.E.; Vitek, M.P. APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J. Neuroimmunol., 2004, 147(1-2), 62-67.
133. Bauer, J.; Strauss, S.; Schreiter-Gasser, U.; Ganter, U.; Schlegel, P.; Witt, I.; Yolk, B.; Berger, M. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett., 1991, 285(1), 111-114.
134. Forloni, G.; Mangiarotti, F.; Angeretti, N.; Lucca, E.; De Simoni, M.G. Beta-amyloid fragment potentiates IL-6 and TNF-alpha secretion by LPS in astrocytes but not in microglia. Cytokine, 1997, 9(10), 759-762.
135. Griffin, W.S.; Stanley, L.C.; Ling, C.; White, L.; MacLeod, V.; Perrot, L.J.; White, C.L., III; Araoz, C. Brain interleukin 1 and S 100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA, 1989, 86(19), 7611-7615.
136. Licastro, F.; Pedrini, S.; Caputo, L.; Annoni, G.; Davis, L.J.; Ferri, C.; Casadei, V.; Grimaldi, L.M. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J. Neuroimmunol., 2000, 103(1), 97-102.
137. Rota, E.; Bellone, G.; Rocca, P.; Bergamasco, B.; Emanuelli, G.; Ferrero, P. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol. Sci., 2006, 27(1), 33-39. (Pubitemid 44026855)
138. Song, D.K.; Im, Y.B.; Jung, J.S.; Cho, J.; Suh, H.W.; Kim, Y.H. Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice. J. Neurochem., 2001, 76(5), 1326-1335.
139. Richartz, E.; Batra, A.; Simon, P.; Wormstall, H.; Bartels, M.; Buchkremer, G.; Schott, K. Diminished production of proinflammatory cytokines in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 2005, 19(4), 184-188. (Pubitemid 40522805)
140. Ray, S.; Britschgi, M.; Herbert, C.; Takeda-Uchimura, Y.; Boxer, A.; Blennow, K.; Friedman, L.F.; Galasko, D.R.; Jutel, M.; Karydas, A.; Kaye, J.A.; Leszek, J.; Miller, B.L.; Minthon, L.; Quinn, J.F.; Rabinovici, G.D.; Robinson, W.H.; Sabbagh, M.N.; So, Y.T.; Sparks, D.L.; Tabaton, M.; Tinklenberg, J.; Yesavage, J.A.; Tibshirani, R.; Wyss-Coray, T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med., 2007, 13(11), 1359-1362.
141. Di Rosa, M.; dell'Ombra, N.; Zambito, A.M.; Malaguarnera, M.; Nicoletti, F.; Malaguarnera, L. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur. J. Neurosci., 2006, 23(10), 2648-2656.
142. Artieda, M.; Cenarro, A.; Ganan, A.; Jerico, I.; Gonzalvo, C.; Casado, J.M.; Vitoria, I.; Puzo, J.; Pocovi, M.; Civeira, F. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler. Thromb. Vasc. Biol., 2003, 23(9), 1645-1652. (Pubitemid 37108211)
143. Brinkman, J.; Wijburg, F.A.; Hollak, C.E.; Groener, J.E.; Verhoek, M.; Scheij, S.; Aten, J.; Boot, R.G.; Aerts, J.M. Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease. J. Inherit. Metab. Dis., 2005, 28(1), 13-20.
144. Hollak, C.E.; van Weely, S.; van Oers, M.H.; Aerts, J.M. Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease. J. Clin. Invest., 1994, 93(3), 1288-1292. (Pubitemid 24087186)
145. Vedder, A.C.; Cox-Brinkman, J.; Hollak, C.E.; Linthorst, G.E.; Groener, J.E.; Helmond, M.T.; Scheij, S.; Aerts, J.M. Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy. Mol. Genet. Metab, 2006, 89(3), 239-244.
146. Schwab, J.M.; Nguyen, T.D.; Meyermann, R.; Schluesener, H.J. Human focal cerebral infarctions induce differential lesional interleukin-16(IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages. J. Neuroimmunol., 2001, 114(1-2), 232-241.
147. Conti, B.; Park, L.C.; Calingasan, N.Y.; Kim, Y.; Kim, H.; Bae, Y.; Gibson, G.E.; Joh, T.H. Cultures of astrocytes and microglia express interleukin 18. Brain Res. Mol. Brain Res., 1999, 67(1), 46-52.
148. Motta, M.; Imbesi, R.; Di, R.M.; Stivala, F.; Malaguarnera, L. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol. Lett., 2007, 114(1), 46-51. (Pubitemid 47625597)
149. Huberman, M.; Shalit, F.; Roth-Deri, I.; Gutman, B.; Brodie, C.; Kott, E.; Sredni, B. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage. J. Neuroimmunol., 1994, 52(2), 147-152 (Pubitemid 24223248)
150. Hull, M.; Pasinetti, G.M.; Aisen, P.S. Elevated plasma neopterin levels in Alzheimer disease. Alzheimer Dis. Assoc. Disord., 2000, 14(4), 228-230.
151. Leblhuber, F.; Walli, J.; Demel, U.; Tilz, G.P.; Widner, B.; Fuchs, D. Increased serum neopterin concentrations in patients with Alzheimer's disease. Clin. Chem. Lab. Med., 1999, 37(4), 429-431. (Pubitemid 29218963)
152. Walter, S.; Letiembre, M.; Liu, Y.; Heine, H.; Penke, B.; Hao, W.; Bode, B.; Manietta, N.; Walter, J.; Schulz-Schuffer, W.; Fassbender, K. Role of the
153. Giunta, M.; Rigamonti, A.E.; Scarpini, E.; Galimberti, D.; Bonomo, S.M.; Venturelli, E.; Muller, E.E.; Cella, S.G. The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging, 2007, 28(4), 515-518. (Pubitemid 46299005)
154. Maes, O.C.; Xu, S.; Yu, B.; Chertkow, H.M.; Wang, E.; Schipper, H.M. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging, 2007, 28(12), 1795-1809. (Pubitemid 47539691)
155. Fiala, M.; Liu, Q.N.; Sayre, J.; Pop, V.; Brahmandam, V.; Graves, M.C.; Vinters, H.V. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest., 2002, 32(5), 360-371.
156. Fiala, M.; Lin, J.; Ringman, J.; Kermani-Arab, V.; Tsao, G.; Patel, A.; Lossinsky, A.S.; Graves, M.C.; Gustavson, A.; Sayre, J.; Sofroni, E.; Suarez, T.; Chiappelli, F.; Bernard, G. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J. Alzheimers Dis., 2005, 7(3), 221-232. (Pubitemid 40917251)
157. Fiala, M.; Liu, P.T.; Espinosa-Jeffrey, A.; Rosenthal, M.J.; Bernard, G.; Ringman, J.M.; Sayre, J.; Zhang, L.; Zaghi, J.; Dejbakhsh, S.; Chiang, B.; Hui, J.; Mahanian, M.; Baghaee, A.; Hong, P.; Cashman, J. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. USA, 2007, 104(31), 12849-12854.
158. Zhang, L.; Fiala, M.; Cashman, J.; Sayre, J.; Espinosa, A.; Mahanian, M.; Zaghi, J.; Badmaev, V.; Graves, M.C.; Bernard, G.; Rosenthal, M. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J. Alzheimers Dis., 2006, 10(1), 1-7. (Pubitemid 44401358)
159. Song, Y.; Morikawa, S.; Morita, M.; Inubushi, T.; Takada, T.; Torii, R.; Kitamura, Y.; Taniguchi, T.; Tooyama, I. Comparison of MR images and histochemical localization of intra-arterially administered microglia surrounding beta-amyloid deposits in the rat brain. Histol. Histopathol., 2006, 21(7), 705-711. (Pubitemid 44082712)
160. Takata, K.; Kitamura, Y.; Yanagisawa, D.; Morikawa, S.; Morita, M.; Inubushi, T.; Tsuchiya, D.; Chishiro, S.; Saeki, M.; Taniguchi, T.; Shimohama, S.; Tooyama, I. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats. FEBS Lett., 2007, 581(3), 475-478. (Pubitemid 46149623)
161. Elimova, E.; Kisilevsky, R.; Szarek, W.A.; Ancsin, J.B. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J, 2004, 18(14), 1749-1751.
162. Gellermann, G.P.; Appel, T.R.; Tannert, A.; Radestock, A.; Hortschansky, P.; Schroeckh, V.; Leisner, C.; Lutkepohl, T.; Shtrasburg, S.; Rocken, C.; Pras, M.; Linke, R.P.; Diekmann, S.; Fandrich, M. Raft lipids as common components of human extracellular amyloid fibrils. Proc. Natl. Acad. Sci. USA, 2005, 102(18), 6297-6302.
163. Gellermann, G.P.; Ullrich, K.; Tannert, A.; Unger, C.; Habicht, G.; Sauter, S.R.; Hortschansky, P.; Horn, U.; Mollmann, U.; Decker, M.; Lehmann, J.; Fandrich, M. Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin. J. Mol. Biol., 2006, 360(2), 251-257. (Pubitemid 43927837)
164. Kluve-Beckerman, B.; Liepnieks, J.J.; Wang, L.; Benson, M.D. A cell culture system for the study of amyloid pathogenesis: amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am. J. Pathol., 1999, 155(1), 123-133.
165. Kluve-Beckerman, B.; Manaloor, J.J.; Liepnieks, J.J. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum., 2002, 46(7), 1905-1913.
166. Gellermann, G.P.; Ullrich, K.; Unger, C.; Fandrich, M.; Sauter, S.; Diekmann, S. Identification of molecular compounds critical to Alzheimer's-like plaque formation. J. Neurosci. Res., 2007, 85(9), 2037-2044. (Pubitemid 47051492)
167. Schulz, B.; Liebisch, G.; Grandl, M.; Werner, T.; Barlage, S.; Schmitz, G. Beta-amyloid(Abeta40, Abeta42) binding to modified LDL accelerates macrophage foam cell formation. Biochim. Biophys. Acta, 2007, 1771(10), 1335-1344.
168. Vance, J.E. Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett., 2006, 580(23), 5518-5524.
169. Kuwabara, P.E.; Labouesse, M. The sterol-sensing domain: multiple families, a unique role? Trends Genet., 2002, 18(4), 193-201. (Pubitemid 34273740)
170. Babalola, J.O.; Wendeler, M.; Breiden, B.; Arenz, C.; Schwarzmann, G.; Locatelli-Hoops, S.; Sandhoff, K. Development of an assay for the intermembrane transfer of cholesterol by Niemann-Pick C2 protein. Biol. Chem., 2007, 388(6), 617-626.
171. Cheruku, S.R.; Xu, Z.; Dutia, R.; Lobel, P.; Storch, J. Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport. J. Biol. Chem., 2006, 281(42), 31594-31604.
172. Davies, J.P.; Chen, F.W.; Ioannou, Y.A. Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science, 2000, 290(5500), 2295-2298.
173. Chen, F.W.; Gordon, R.E.; Ioannou, Y.A. NPC1 late endosomes contain elevated levels of non-esterified('free') fatty acids and an abnormally glycosylated form of the NPC2 protein. Biochem. J., 2005, 390(Pt 2), 549-561.
174. Passeggio, J.; Liscum, L. Flux of fatty acids through NPC1 lysosomes. J. Biol. Chem., 2005, 280(11), 10333-10339.
175. Infante, R.E.; bi-Mosleh, L.; Radhakrishnan, A.; Dale, J.D.; Brown, M.S.; Goldstein, J.L. Purified NPC1 Protein: I. binding of cholesterol and oxysterols to a 1278-amino acid membrane protein. J. Biol. Chem., 2008, 283(2), 1052-1063.
176. Choi, H.Y.; Karten, B.; Chan, T.; Vance, J.E.; Greer, W.L.; Heidenreich, R.A.; Garver, W.S.; Francis, G.A. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J. Biol. Chem., 2003, 278(35), 32569-32577.
177. Higashi, Y.; Murayama, S.; Pentchev, P.G.; Suzuki, K. Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol.(Berl), 1993, 85(2), 175-184. (Pubitemid 23068507)
178. Baudry, M.; Yao, Y.; Simmons, D.; Liu, J.; Bi, X. Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp. Neurol., 2003, 184(2), 887-903. (Pubitemid 38182817)
179. Wu, Y.P.; Mizukami, H.; Matsuda, J.; Saito, Y.; Proia, R.L.; Suzuki, K. Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol. Genet. Metab., 2005, 84(1), 9-17. (Pubitemid 40082600)
180. Bi, X.; Liao, G. Autophagic-lysosomal dysfunction and neurodegeneration in niemann-pick type C mice: lipid starvation or indigestion? Autophagy, 2007, 3(6), 646-648 (Pubitemid 350060071)
181. Tashiro, Y.; Yamazaki, T.; Shimada, Y.; Ohno-Iwashita, Y.; Okamoto, K. Axon-dominant localization of cell-surface cholesterol in cultured hippocampal neurons and its disappearance in Niemann-Pick type C model cells. Eur. J. Neurosci., 2004, 20(8), 2015-2021. (Pubitemid 39331121)
182. Yu, W.; Gong, J.S.; Ko, M.; Garver, W.S.; Yanagisawa, K.; Michikawa, M. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J. Biol. Chem., 2005, 280(12), 11731-11739. (Pubitemid 40418487)
183. Huang, Z.; Hou, Q.; Cheung, N.S.; Li, Q.T. Neuronal cell death caused by inhibition of intracellular cholesterol trafficking is caspase dependent and associated with activation of the mitochondrial apoptosis pathway. J. Neurochem., 2006, 97(1), 280-291
184. Suzuki, K.; Parker, C.C.; Pentchev, P.G.; Katz, D.; Ghetti, B.; D'Agostino, A.N.; Carstea, E.D. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol.(Berl), 1995, 89(3), 227-238.
185. Jin, L.W.; Shie, F.S.; Maezawa, I.; Vincent, I.; Bird, T. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am. J. Pathol., 2004, 164(3), 975-985. (Pubitemid 38235479)
186. Wolf, Z.; Orso, E.; Werner, T.; Klunemann, H.H.; Schmitz, G. Monocyte cholesterol homeostasis correlates with the presence of detergent resistant membrane microdomains. Cytometry A, 2007, 71(7), 486-494. (Pubitemid 47036039)
187. Chou, K.L.; Hurtig, H.I. In Parkinson's Disease; Ebadi, M.; Pfeiffer, R.F., Eds.; CRC Press: New York, 2005; Vol., pp. 171-181.
188. Goedert, M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci., 2001, 2(7), 492-501.
189. Spillantini, M.G.; Schmidt, M.L.; Lee, V.M.; Trojanowski, J.Q.; Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature, 1997, 388(6645), 839-840.
190. Kruger, R.; Kuhn, W.; Muller, T.; Woitalla, D.; Graeber, M.; Kosel, S.; Przuntek, H.; Epplen, J.T.; Schols, L.; Riess, O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 1998, 18(2), 106-108.
191. Polymeropoulos, M.H.; Lavedan, C.; Leroy, E.; Ide, S.E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E.S.; Chandrasekharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W.G.; Lazzarini, A.M.; Duvoisin, R.C.; Di Iorio, G.; Golbe, L.I.; Nussbaum, R.L. Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science, 1997, 276(5321), 2045-2047.
192. Zarranz, J.J.; Alegre, J.; Gomez-Esteban, J.C.; Lezcano, E.; Ros, R.; Ampuero, I.; Vidal, L.; Hoenicka, J.; Rodriguez, O.; Atares, B.; Llorens, V.; Gomez, T.E.; del Ser, T.; Munoz, D.G.; de Yebenes, J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol., 2004, 55(2), 164-173.
193. Bennett, M.C.; Bishop, J.F.; Leng, Y.; Chock, P.B.; Chase, T.N.; Mouradian, M.M. Degradation of alpha-synuclein by proteasome. J. Biol. Chem., 1999, 274(48), 33855-33858.
194. Cuervo, A.M.; Stefanis, L.; Fredenburg, R.; Lansbury, P.T.; Sulzer, D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science, 2004, 305(5688), 1292-1295.
195. Farrer, M.; Hardy, J.; Hutton, M.; Maraganore, D.; Tsuboi, Y.; Wszolek, Z.K. Identifying genetic factors in Parkinson disease. JAMA, 2002, 287(6), 715-716.
196. Moore, D.J.; West, A.B.; Dawson, V.L.; Dawson, T.M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci., 2005, 28, 57-87 (Pubitemid 41098899)
197. Wood-Kaczmar, A.; Gandhi, S.; Wood, N.W. Understanding the molecular causes of Parkinson's disease. Trends Mol. Med., 2006, 12(11), 521-528.
198. Schlehe, J.S.; Lutz, A.K.; Pilsl, A.; Lammermann, K.; Grgur, K.; Henn, I.H.; Tatzelt, J.; Winklhofer, K.F. aberrant folding of pathogenic parkin mutants: aggregation versus degradation. J. Biol. Chem., 2008, 283(20), 13771-13779.
199. Imai, Y.; Soda, M.; Takahashi, R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 2000, 275(46), 35661-35664.
200. Shimura, H.; Hattori, N.; Kubo, S.; Mizuno, Y.; Asakawa, S.; Minoshima, S.; Shimizu, N.; Iwai, K.; Chiba, T.; Tanaka, K.; Suzuki, T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 2000, 25(3), 302-305. (Pubitemid 30437317)
201. Zhang, Y.; Gao, J.; Chung, K.K.; Huang, H.; Dawson, V.L.; Dawson, T.M. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA, 2000, 97(24), 13354-13359.
202. Whitton, P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol., 2007, 150(8), 963-976. (Pubitemid 46628616)
203. Alam, Z.I.; Jenner, A.; Daniel, S.E.; Lees, A.J.; Cairns, N.; Marsden, C.D.; Jenner, P.; Halliwell, B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem., 1997, 69(3), 1196-1203. (Pubitemid 27364841)
204. Dexter, D.T.; Carter, C.J.; Wells, F.R.; Javoy-Agid, F.; Agid, Y.; Lees, A.; Jenner, P.; Marsden, C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem., 1989, 52(2), 381-389. (Pubitemid 19037600)
205. Floor, E.; Wetzel, M.G. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem., 1998, 70(1), 268-275.
206. Hirsch, E.C.; Hunot, S.; Damier, P.; Faucheux, B. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol., 1998, 44(3 Suppl 1), S115-S120. (Pubitemid 28423837)
207. Wullner, U.; Klockgether, T. Inflammation in Parkinson's disease. J. Neurol., 2003, 250,(Suppl 1), I35-I38.
208. Blum-Degen, D.; Muller, T.; Kuhn, W.; Gerlach, M.; Przuntek, H.; Riederer, P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett., 1995, 202(1-2), 17-20. (Pubitemid 3013129)
209. Mogi, M.; Harada, M.; Kondo, T.; Riederer, P.; Inagaki, H.; Minami, M.; Nagatsu, T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett., 1994, 180(2), 147-150. (Pubitemid 2157863)
210. Muller, T.; Blum-Degen, D.; Przuntek, H.; Kuhn, W. Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease. Acta Neurol. Scand., 1998, 98(2), 142-144. (Pubitemid 28351288)
211. Knott, C.; Stern, G.; Wilkin, G.P. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol. Cell Neurosci., 2000, 16(6), 724-739.
212. McGeer, P.L.; Itagaki, S.; Boyes, B.E.; McGeer, E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology, 1988, 38(8), 1285-1291.
213. Zhang, W.; Wang, T.; Pei, Z.; Miller, D.S.; Wu, X.; Block, M.L.; Wilson, B.; Zhang, W.; Zhou, Y.; Hong, J.S.; Zhang, J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J, 2005, 19(6), 533-542.
214. Klegeris, A.; Pelech, S.; Giasson, B.I.; Maguire, J.; Zhang, H.; McGeer, E.G.; McGeer, P.L. Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol. Aging, 2008, 29(5), 739-752.
215. Kim, Y.S.; Kim, S.S.; Cho, J.J.; Choi, D.H.; Hwang, O.; Shin, D.H.; Chun, H.S.; Beal, M.F.; Joh, T.H. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neurosci., 2005, 25(14), 3701-3711. (Pubitemid 40503697)
216. Wilms, H.; Rosenstiel, P.; Sievers, J.; Deuschl, G.; Zecca, L.; Lucius, R. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J, 2003, 17(3), 500-502.
217. Zecca, L.; Zucca, F.A.; Wilms, H.; Sulzer, D. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci., 2003, 26(11), 578-580.
218. Qian, L.; Hong, J.S.; Flood, P.M. Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10. J. Neural Transm. Suppl., 2006,(70), 367-371.
219. Mount, M.P.; Lira, A.; Grimes, D.; Smith, P.D.; Faucher, S.; Slack, R.; Anisman, H.; Hayley, S.; Park, D.S. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J. Neurosci., 2007, 27(12), 3328-3337. (Pubitemid 46474138)
220. Reynolds, A.D.; Glanzer, J.G.; Kadiu, I.; Ricardo-Dukelow, M.; Chaudhuri, A.; Ciborowski, P.; Cerny, R.; Gelman, B.; Thomas, M.P.; Mosley, R.L.; Gendelman, H.E. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. J. Neurochem., 2008, 104(6), 1504-1525. (Pubitemid 351316759)
221. Kortekaas, R.; Leenders, K.L.; van Oostrom, J.C.; Vaalburg, W.; Bart, J.; Willemsen, A.T.; Hendrikse, N.H. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann. Neurol., 2005, 57(2), 176-179. (Pubitemid 40179854)
222. Kokovay, E.; Cunningham, L.A. Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease. Neurobiol. Dis., 2005, 19(3), 471-478.
223. Shavali, S.; Combs, C.K.; Ebadi, M. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease. Neurochem. Res., 2006, 31(1), 85-94. (Pubitemid 43234549)
224. Widner, B.; Leblhuber, F.; Fuchs, D. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease. J. Neural Transm., 2002, 109(2), 181-189. (Pubitemid 34185664)
225. Rentzos, M.; Nikolaou, C.; Andreadou, E.; Paraskevas, G.P.; Rombos, A.; Zoga, M.; Tsoutsou, A.; Boufidou, F.; Kapaki, E.; Vassilopoulos, D. Circulating interleukin-15 and RANTES chemokine in Parkinson's disease. Acta Neurol. Scand., 2007, 116(6), 374-379. (Pubitemid 350045501)
226. Reale, M.; Iarlori, C.; Thomas, A.; Gambi, D.; Perfetti, B.; Di, N.M.; Onofrj, M. Peripheral cytokines profile in Parkinson's disease. Brain Behav. Immun., 2009, 23(1), 55-63.
227. Trapp, B.D.; Peterson, J.; Ransohoff, R.M.; Rudick, R.; Mork, S.; Bo, L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med., 1998, 338(5), 278-285. (Pubitemid 28065253)
228. Trapp, B.D.; Ransohoff, R.; Rudick, R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol., 1999, 12(3), 295-302. (Pubitemid 29378163)
229. Kutzelnigg, A.; Lucchinetti, C.F.; Stadelmann, C.; Bruck, W.; Rauschka, H.; Bergmann, M.; Schmidbauer, M.; Parisi, J.E.; Lassmann, H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain, 2005, 128(Pt 11), 2705-2712. (Pubitemid 41552953)
230. Takeuchi, H.; Wang, J.; Kawanokuchi, J.; Mitsuma, N.; Mizuno, T.; Suzumura, A. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis. Neurobiol. Dis., 2006, 22(1), 33-39.
231. Cannella, B.; Raine, C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol., 1995, 37(4), 424-435.
232. Gerritse, K.; Laman, J.D.; Noelle, R.J.; Aruffo, A.; Ledbetter, J.A.; Boersma, W.J.; Claassen, E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA, 1996, 93(6), 2499-2504. (Pubitemid 26104798)
233. Chao, C.C.; Hu, S.; Sheng, W.S.; Peterson, P.K. Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev. Neurosci., 1995, 17(2), 97-105.
234. Merrill, J.E.; Ignarro, L.J.; Sherman, M.P.; Melinek, J.; Lane, T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol., 1993, 151(4), 2132-2141. (Pubitemid 23235686)
235. Dalakas, M.; Wright, R.G.; Prineas, J.W. Nature of the reversible white matter lesion in multiple sclerosis: effects of acute inflammation on myelinated tissue studied in the rabbit eye. Brain, 1980, 103(3), 515-524.
236. Prineas, J.W.; Wright, R.G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest., 1978, 38(4), 409-421.
237. Heppner, F.L.; Greter, M.; Marino, D.; Falsig, J.; Raivich, G.; Hovelmeyer, N.; Waisman, A.; Rulicke, T.; Prinz, M.; Priller, J.; Becher, B.; Aguzzi, A. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med., 2005, 11(2), 146-152. (Pubitemid 40321349)
238. Huitinga, I.; van Rooijen, N.; De Groot, C.J.; Uitdehaag, B.M.; Dijkstra, C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med., 1990, 172(4), 1025-1033. (Pubitemid 20343201)
239. Filbin, M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci., 2003, 4(9), 703-713.
240. Makranz, C.; Cohen, G.; Baron, A.; Levidor, L.; Kodama, T.; Reichert, F.; Rotshenker, S. Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cgamma and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined with scavenger receptor-AI/II in macrophages. Neurobiol. Dis., 2004, 15(2), 279-286. (Pubitemid 38296759)
241. Reichert, F.; Rotshenker, S. Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages. Neurobiol. Dis., 2003, 12(1), 65-72.
242. Bartnik, B.L.; Juurlink, B.H.; Devon, R.M. Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress. Mult. Scler., 2000, 6(1), 37-42.
243. Stadelmann, C.; Kerschensteiner, M.; Misgeld, T.; Bruck, W.; Hohlfeld, R.; Lassmann, H. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain, 2002, 125(Pt 1), 75-85.
244. Weinstock-Guttman, B.; Zivadinov, R.; Tamano-Blanco, M.; Abdelrahman, N.; Badgett, D.; Durfee, J.; Hussein, S.; Feichter, J.; Patrick, K.; Benedict, R.; Ramanathan, M. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis. J. Neuroimmunol., 2007, 188(1-2), 167-174.
245. Azoulay, D.; Urshansky, N.; Karni, A. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J. Neuroimmunol., 2008, 195(1-2), 186-193
246. Sellebjerg, F.; Kristiansen, T.B.; Wittenhagen, P.; Garred, P.; Eugen-Olsen, J.; Frederiksen, J.L.; Sorensen, T.L. Chemokine receptor CCR5 in interferon-treated multiple sclerosis. Acta Neurol. Scand., 2007, 115(6), 413-418.
247. Liu, G.Z.; Gomes, A.C.; Putheti, P.; Karrenbauer, V.; Kostulas, K.; Press, R.; Hillert, J.; Hjelmstrom, P.; Gao, X.G. Increased soluble 4-1BB ligand(4-1BBL) levels in peripheral blood of patients with multiple sclerosis. Scand. J. Immunol., 2006, 64(4), 412-419. (Pubitemid 44408797)
248. Frisullo, G.; Angelucci, F.; Caggiula, M.; Nociti, V.; Iorio, R.; Patanella, A.K.; Sancricca, C.; Mirabella, M.; Tonali, P.A.; Batocchi, A.P. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res., 2006, 84(5), 1027-1036.
249. Paty, D.W.; Li, D.K. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology, 1993, 43(4), 662-667.
250. Wiesemann, E.; Deb, M.; Trebst, C.; Hemmer, B.; Stangel, M.; Windhagen, A. Effects of interferon-{beta} on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-{beta} treatment in patients with multiple sclerosis. Mult. Scler., 2008, 14(2), 166-176. (Pubitemid 351639624)
251. Budka, H. The definition of HIV-specific neuropathology. Acta Pathol. Jpn., 1991, 41(3), 182-191.
252. Masliah, E.; Ge, N.; Achim, C.L.; DeTeresa, R.; Wiley, C.A. Patterns of neurodegeneration in HIV encephalitis. J. NeuroAIDS., 1996, 1(1), 161-173.
253. Rumbaugh, J.A.; Nath, A. Developments in HIV neuropathogenesis. Curr. Pharm. Des., 2006, 12(9), 1023-1044.
254. Jordan, C.A.; Watkins, B.A.; Kufta, C.; Dubois-Dalcq, M. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J. Virol., 1991, 65(2), 736-742.
255. Ryzhova, E.V.; Crino, P.; Shawver, L.; Westmoreland, S.V.; Lackner, A.A.; Gonzalez-Scarano, F. Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples. Virology, 2002, 297(1), 57-67. (Pubitemid 34734910)
256. Avison, M.J.; Nath, A.; Greene-Avison, R.; Schmitt, F.A.; Bales, R.A.; Ethisham, A.; Greenberg, R.N.; Berger, J.R. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J. Neurovirol., 2004, 10(4), 223-232.
257. Sheng, W.S.; Hu, S.; Hegg, C.C.; Thayer, S.A.; Peterson, P.K. Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin. Immunol., 2000, 96(3), 243-251.
258. Ryan, L.A.; Cotter, R.L.; Zink, W.E.; Gendelman, H.E.; Zheng, J. Macrophages, chemokines and neuronal injury in HIV-1-associated dementia. Cell Mol. Biol.(Noisy. -le-grand), 2002, 48(2), 137-150.
259. Wilt, S.G.; Milward, E.; Zhou, J.M.; Nagasato, K.; Patton, H.; Rusten, R.; Griffin, D.E.; O'Connor, M.; Dubois-Dalcq, M. In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol., 1995, 37(3), 381-394.
260. Adamson, D.C.; Wildemann, B.; Sasaki, M.; Glass, J.D.; McArthur, J.C.; Christov, V.I.; Dawson, T.M.; Dawson, V.L. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science, 1996, 274(5294), 1917-1921.
261. Schmidtmayerova, H.; Nottet, H.S.; Nuovo, G.; Raabe, T.; Flanagan, C.R.; Dubrovsky, L.; Gendelman, H.E.; Cerami, A.; Bukrinsky, M.; Sherry, B. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA, 1996, 93(2), 700-704.
262. Sui, Z.; Sniderhan, L.F.; Schifitto, G.; Phipps, R.P.; Gelbard, H.A.; Dewhurst, S.; Maggirwar, S.B. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J. Immunol., 2007, 178(5), 3226-3236.
263. Tanzi, R.E. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J. Clin. Invest., 1999, 104(9), 1175-1179.
264. Bertram, L.; McQueen, M.B.; Mullin, K.; Blacker, D.; Tanzi, R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet., 2007, 39(1), 17-23.
265. Wayne, M.L.; McIntyre, L.M. Combining mapping and arraying: An approach to candidate gene identification. Proc. Natl. Acad. Sci. USA, 2002, 99(23), 14903-14906.
266. Ashley-Koch, A.E.; Shao, Y.; Rimmler, J.B.; Gaskell, P.C.; Welsh-Bohmer, K.A.; Jackson, C.E.; Scott, W.K.; Haines, J.L.; Pericak-Vance, M.A. An autosomal genomic screen for dementia in an extended Amish family. Neurosci. Lett., 2005, 379(3), 199-204.
267. Blacker, D.; Bertram, L.; Saunders, A.J.; Moscarillo, T.J.; Albert, M.S.; Wiener, H.; Perry, R.T.; Collins, J.S.; Harrell, L.E.; Go, R.C.; Mahoney, A.; Beaty, T.; Fallin, M.D.; Avramopoulos, D.; Chase, G.A.; Folstein, M.F.; McInnis, M.G.; Bassett, S.S.; Doheny, K.J.; Pugh, E.W.; Tanzi, R.E. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet., 2003, 12(1), 23-32.
268. Rademakers, R.; Cruts, M.; Sleegers, K.; Dermaut, B.; Theuns, J.; Aulchenko, Y.; Weckx, S.; DePooter, T.; Van den Broeck, M.; Corsmit, E.; De Rijk, P.; Del-Favero, J.; van Swieten, J.; van Duijn, C.M.; Van Broeckhoven, C. Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am. J. Hum. Genet., 2005, 77(4), 643-652.